MCF Advisors’s ResMed RMD Stock Holding History

MCF Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$697K	Buy	+3,103	New	+$773K	0.03%	203
2025 Q4	–	Sell	-12	Closed	-$3.29K	–	1177
2025 Q3	$3.29K	Buy	+12	New	+$3.28K	﹤0.01%	846
2025 Q1	–	Sell	-8	Closed	-$1.83K	–	1003
2024 Q4	$1.83K	Sell	8 -2	-20%	-$482	﹤0.01%	856
2024 Q3	$2.44K	Hold	10	–	–	﹤0.01%	828
2024 Q2	$1.92K	Hold	10	–	–	﹤0.01%	852
2024 Q1	$1.98K	Buy	10 +2	+25%	+$366	﹤0.01%	822
2023 Q4	$1.38K	Buy	8 +4	+100%	+$615	﹤0.01%	809
2023 Q3	$592	Hold	4	–	–	﹤0.01%	868
2023 Q2	$874	Hold	4	–	–	﹤0.01%	794
2023 Q1	$876	Hold	4	–	–	﹤0.01%	780
2022 Q4	$833	Hold	4	–	–	﹤0.01%	757
2022 Q3	$1K	Hold	4	–	–	﹤0.01%	770
2022 Q2	$1K	Hold	4	–	–	﹤0.01%	729
2022 Q1	$1K	Buy	+4	New	+$968	﹤0.01%	737
2021 Q4	–	Sell	-4	Closed	-$1K	–	537
2021 Q3	$1K	Buy	+4	New	+$1.09K	﹤0.01%	721

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MCF Advisors's RMD Position: Q1 2026 in Review

MCF Advisors opened a new position in ResMed (RMD) in Q1 2026: 3,103 shares worth $697K. The stake represents 0.03% of the portfolio and ranks #203 among its holdings. This is a return to the name: MCF Advisors previously reported a position in RMD as recently as Q3 2025.

MCF Advisors first reported a position in RMD in Q3 2021 and has held it in 15 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

MCF Advisors held 3,103 shares of ResMed worth $697K as of Q1 2026.
ResMed was a new MCF Advisors position in Q1 2026.
ResMed made up 0.03% of MCF Advisors's portfolio in Q1 2026, its #203 holding.
MCF Advisors first reported a position in ResMed in Q3 2021 and has held it in 15 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.